Wellgistics Health, Inc. financial data

Symbol
WGRX on Nasdaq
Location
Tampa, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 19 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 36% %
Quick Ratio 22% %
Debt-to-equity 1077% %
Return On Equity -1646% %
Return On Assets -140% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 89,729,281 shares
Common Stock, Shares, Outstanding 89,452,911 shares
Common Stock, Value, Issued $8,945 USD
Weighted Average Number of Shares Outstanding, Basic 74,379,403 shares 54%
Weighted Average Number of Shares Outstanding, Diluted 74,379,403 shares 54%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,012,904 USD -47%
Cost of Revenue $2,781,892 USD -46%
Selling and Marketing Expense $803,747 USD
General and Administrative Expense $70,554,638 USD 1578%
Operating Income (Loss) $72,144,605 USD -1708%
Nonoperating Income (Expense) $5,608,718 USD -2167%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $77,753,323 USD -1738%
Net Income (Loss) Attributable to Parent $77,753,323 USD -1738%
Earnings Per Share, Basic -1 USD/shares -1050%
Earnings Per Share, Diluted -1 USD/shares -1050%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,228,666 USD
Inventory, Net $7,491,900 USD
Assets, Current $12,820,490 USD
Property, Plant and Equipment, Net $268,911 USD
Operating Lease, Right-of-Use Asset $1,019,848 USD
Intangible Assets, Net (Excluding Goodwill) $2,244,161 USD
Goodwill $16,219,929 USD
Other Assets, Noncurrent $1,459,607 USD
Assets $52,779,540 USD
Liabilities, Current $32,741,039 USD
Operating Lease, Liability, Noncurrent $660,486 USD
Liabilities $46,001,525 USD
Retained Earnings (Accumulated Deficit) $83,178,731 USD
Stockholders' Equity Attributable to Parent $6,778,015 USD -32%
Liabilities and Equity $52,779,540 USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,347,449 USD -4414%
Net Cash Provided by (Used in) Financing Activities $3,108,831 USD 1096%
Net Cash Provided by (Used in) Investing Activities $273,133 USD
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 91,406,962 shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,488,249 USD 411%
Interest Paid, Excluding Capitalized Interest, Operating Activities $616,072 USD
Deferred Tax Assets, Valuation Allowance $2,467,687 USD 236%
Operating Lease, Liability $1,249,096 USD
Depreciation $39,731 USD 46%
Lessee, Operating Lease, Liability, to be Paid $1,163,897 USD
Property, Plant and Equipment, Gross $1,507,836 USD
Operating Lease, Liability, Current $503,411 USD
Lessee, Operating Lease, Liability, to be Paid, Year Two $458,657 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $566,514 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, to be Paid, Year Three $84,977 USD
Deferred Tax Assets, Operating Loss Carryforwards $2,467,687 USD 236%
Additional Paid in Capital $89,947,801 USD
Amortization of Intangible Assets $12,308 USD
Share-based Payment Arrangement, Expense $25,716,523 USD